VCELのPER（株価収益率）は？

Vericel Corp Ord（VCEL）は現在PER 77.10倍で取引されています。

VCELのROE（自己資本利益率）は？

Vericel Corp OrdのROEは6.55%です。

VCELの配当利回りは？

Vericel Corp Ordの配当利回りは0.00%です。

VCELの品質スコア（Quality Score）は？

当社のAIはVCELの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

VCELは今が買い時ですか？

当社AIのタイミングスコアは100点中87点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

VCELはどのセクターに属しますか？

Vericel Corp OrdはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

VCEL (NASDAQ) 株価分析 | VERICEL CORP ORD

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-06-30)

VCEL AI Analysis Summary

Our AI summary for VCEL: Vericel Corp Ord (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 77.10, ROE of 6.55%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

VCEL

Vericel Corp Ord

US:NASDAQ STOCK Healthcare >> Biotechnology

USD 46.05

0.09 (0.20%) Day Change

Watchlist Portfolio Compare Chart

77.10

P/E

0.04

D/E

6.6%

ROE

4.8%

ROA

0.00%

Div Yield

-0.55

PEG

VERICEL CORP ORD
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 46.05 Price 0.09 (0.20%) Day Change	NEWS SCORE: N/A

VCEL, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROEが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	2695
Magic Formula Rank by ROE	2695
Magic Formula Rank by ROIC	2745
Price	46.05
PBV / Sector	6.36 / 44,219.29
Earning Per Share	0.47

PE / Sector	77.10 / 19.28
PEG or PE/Growth / Sector	-0.55 / 1.23
Average 1M Daily Value	23.17 M GREAT
Average 1W Daily Value	27.18 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	7.91 / 98.22
NPM Average (%) / Sector	1.30 / -1,697.63
NPM Change Average (%) / Sector	-96.54 / 5,097.97
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	4.82 / 185,260.96
ROA Average (%) / Sector	0.72 / 36,684.70
ROA Change Average (%) / Sector	-91.95 / 422,221.66
ROE (%) / Sector	6.55 / 243,762.23
ROE Average (%) / Sector	0.93 / 48,758.47
ROE Change Average (%) / Sector	-91.01 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

登録情報

Analyze Date	2026-08-04 08:02:19
Symbol	VCEL
Name	VERICEL CORP ORD
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	51.21 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	2,353.46 / 9,645.64

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 25 Blue Sky Drive, Burlington, MA, United States, 01803

Phone: 617 588 5555

Website: https://www.vcel.com

Employees: 398

Sector: Healthcare >> Biotechnology

Description: Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.